Accelerate the Development of T-Cell Engagers in Autoimmune Indications Through Reducing CRS Toxicities, Improve Tissue Targeted Depletion & Expand Targets Beyond B-Cells.
The T-Cell Engager for Autoimmune Disease Summit is the first event dedicated entirely to advancing TCE therapies for autoimmune and inflammatory conditions. Over three days, this focused meeting brings together top immunology experts, pioneering biotech leaders, and pharmaceutical innovators to address critical challenges in design, safety, and clinical application.
View Event
